Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Macrophages have an important role in the maintenance of tissue homeostasis. To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition. Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth. However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, tumor cells produce lactate which induces the M2 phenotype of TAMs via stabilizing HIF‐1α and activating G‐protein‐coupled receptor 132 [210, 233, 234].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [233]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lactate is known to promote tumor growth [142], angiogenesis [143], and polarize macrophages to express a pro-tumor M2 phenotype [144].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [144]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies have demonstrated that lactate can improve the stability of the HIF-1α protein [9–11].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These findings indicate that lactate derived from the tumor microenvironment might facilitate HIF-1α-regulated angiogenesis in a hypoxia-independent manner [9].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Cited by
Items 701–800 of 1,014
Chen, P., Wu, M., He, Y., Jiang, B., & He, M. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01510-8 · Cited by 93
“By stabilizing HIF-1α, lactate promotes glycolysis in a positive feedback manner, thus facilitating SARS-CoV-2 infection.(347,348) Intriguingly, lactate is also a suppressor of RLRmediated innate immunity.”
BackgroundTumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer
Cascone, T., Fradette, J. J., Pradhan, M., & Gibbons, D. L. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037895 · Cited by 100
Immunometabolism in cancer at a glance
Singer, K., Cheng, W.-C., Kreutz, M. P., Ho, P., & Siska, P. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034272 · Cited by 92
Caslin, H. L., Abebayehu, D., Abdul Qayum, A., Haque, T. T., Taruselli, M. T., Paez, P. A., Pondicherry, N., Barnstein, B. O., Hoeferlin, L. A., Chalfant, C. E., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801005 · Cited by 82
“, M2 macrophage lineage and myeloid-derived suppressor cells) (18, 19).”
BackgroundPhotoacoustic imaging as a tool to probe the tumour microenvironment
Brown, E. L., Brunker, J., & Bohndiek, S. E. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039636 · Cited by 92
Biology and therapeutic targeting of tumour‐associated macrophages
Beltraminelli, T., & De Palma, M. (2020) · The Journal of Pathology · doi:10.1002/path.5403 · Cited by 86
“Furthermore, hypoxic cancer cells secrete lactate, which enhancesM2-like programming of TAMs [120,121].”
BackgroundTargeting tumor-associated macrophages in head and neck squamous cell carcinoma
Li, B., Ren, M., Zhou, X., Han, Q., & Cheng, L. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104723 · Cited by 91
Li, J., Zhao, M. F., Sun, M. Z., Wu, S., Zhang, H., Dai, Y., & Wang, D. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c14909 · Cited by 89
Tong, N., He, Z., Ma, Y., Wang, Z., Huang, Z., Cao, H., Xu, L., Zou, Y., Wang, W., Yi, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.706286 · Cited by 99
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy
Jayaprakash, P., Vignali, P. D. A., Delgoffe, G. M., & Curran, M. A. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-060619-022830 · Cited by 87
Yang, L. G., Wang, Y., Liu, W., Ma, H., Yang, B., Shao, K., Long, S., Sun, W. C., Du, J., Fan, J., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122089 · Cited by 88
Myeloid cell plasticity in the evolution of central nervous system autoimmunity
Giles, D. A., Washnock‐Schmid, J. M., Duncker, P. C., Dahlawi, S., Ponath, G., Pitt, D., & Segal, B. M. (2018) · Annals of Neurology · doi:10.1002/ana.25128 · Cited by 82
“Candidates include hypoxia-inducible factor 1a and peroxisome proliferator-activated receptor c, which have been shown to promote AAMC differentiation in other experimental systems.(45,46) Alternatively, studies with primary human macrophages suggest that ingestion of myelin could trigger their development.”
BackgroundInsulin Resistance in Macrophages Alters Their Metabolism and Promotes an M2-Like Phenotype
Ieronymaki, E., Theodorakis, E. M., Lyroni, K., Vergadi, E., Lagoudaki, E. D., Al-Qahtani, A. A., Aznaourova, M., Neofotistou-Themeli, E., Eliopoulos, A. G., Vaporidi, K., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800065 · Cited by 93
“Tumorassociated macrophages (TAMs) acquire an M2-like phenotype characterized by increased glycolysis (24) and the end product of glycolysis, lactic acid, produced in the tumor microenvironment triggers the expression of M2 activation markers (25), whereas IL-4–induced M2 macrophages display increased glycolysis and i…”
BackgroundHypoxia and Metabolism in Metastasis
Zhang, T., Suo, C., Zheng, C., & Zhang, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_6 · Cited by 96
Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages
Alaluf, E., Vokaer, B., Detavernier, A., Azouz, A., Splittgerber, M., Carrette, A., Boon, L., Libert, F., Soares, M. P., Moine, A. L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133929 · Cited by 113
“Hence, other signals, such as tissue hypoxia or accumulation of lactic acid, key metabolic features of the TME (58, 59), could induce HO-1 through the activation of HIF1α (60).”
Background1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer
Kilgour, M. K., MacPherson, S., Zacharias, L. G., Ellis, A. E., Sheldon, R. D., Liu, E. Y., Keyes, S., Pauly, B., Carleton, G. A., Allard, B., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe1174 · Cited by 92
Arginine metabolism in myeloid cells in health and disease
Karadima, E., Chavakis, T., & Alexaki, V. I. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01038-9 · Cited by 97
“Collagen taken up by TAMs is a rich source of arginine, which is further metabolized by ARG1 and iNOS [151–153].”
Li, Q., Zhang, X., Zhang, C., Zhang, Y., Niu, M., Chen, Z., Zhang, S., He, J., Chen, W., & Zhang, X.-Z. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05148 · Cited by 92
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
“In addition to the cytokines described above, TAM activation can be influenced by hypoxia and local metabolite concentrations such as lactate (Casazza et al., 2013; Colegio et al., 2014; Carmona-Fontaine et al., 2017).”
BackgroundTherapeutic effects of CSF1R-blocking antibodies in multiple myeloma
Wang, Q., Lu, Y., Li, R., Jiang, Y., Zheng, Y., Qian, J., Bi, E., Zheng, C., Hou, J., Wang, S., et al. (2017) · Leukemia · doi:10.1038/leu.2017.193 · Cited by 89
Lactate transporters as therapeutic targets in cancer and inflammatory diseases
Pucino, V., Cucchi, D., & Mauro, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1511706 · Cited by 90
“Similarly and in agreement with [5], Sonveaux et al.”
BackgroundResultInfluentialLncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling
Yang, J., Liu, F., Wang, Y., Qu, L., & Lin, A. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215798 · Cited by 93
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Shan, J., Han, D. H., Shen, C., Lei, Q., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016646 · Cited by 97
Zhang, Y., Du, X., He, Z., Gao, S., Ye, L., Ji, J., Yang, X., & Zhai, G. (2023) · ACS Nano · doi:10.1021/acsnano.3c01527 · Cited by 89
Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
Sun, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21338 · Cited by 83
Kosumi, K., Hamada, T., Koh, H., Borowsky, J., Bullman, S., Twombly, T. S., Nevo, D., Masugi, Y., Liu, L., da Silva, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.015 · Cited by 91
Maimon, A., Levi-Yahid, V., Ben‐Meir, K., Halpern, A., Talmi, Z., Priya, S., Mizraji, G., Mistriel-Zerbib, S., Berger, M., Baniyash, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci126089 · Cited by 89
“Examples include macrophage polarization toward an M2-like immunosuppressive phenotype by tumor-secreted lactic acid (6) and the induction of the proinflammatory cytokines TNF-α and IL-6 within macrophages by tumor-derived versican, leading to increased metastasis (7).”
Yu, N., Zhou, J., Ding, M., Li, M., Peng, S., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405639 · Cited by 90
Feichtinger, R. G., & Lang, R. (2019) · Journal of Oncology · doi:10.1155/2019/2084195 · Cited by 80
“Tumor-derived lactate drives macrophage polarization toward a tumor-promoting phenotype in mice [67], where HIF-1α-dependent lactate-induced expression of arginase 1 and VEGF might also contribute to immunosuppression and tumor evasion [67–69].”
BackgroundEvolution of placental invasion and cancer metastasis are causally linked
Gupta, K., Afzal, J. M., Maziarz, J. D., Hamidzadeh, A., Liang, C., Erkenbrack, E. M., Kim, H. N., Häeger, J.-D., Pfarrer, C. D., Hoang, T. S., et al. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-019-1046-4 · Cited by 95
Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
Wagner, M., Ealey, K. N., Tetsu, H., Kiniwa, T., Motomura, Y., Moro, K., & Koyasu, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.103 · Cited by 86
Virtuoso, A., Giovannoni, R., Luca, C. D., Gargano, F., Cerasuolo, M., Maggio, N., Lavitrano, M., & Papa, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073301 · Cited by 85
Cao, S., Saw, P. E., Shen, Q., Li, R., Liu, Y., & Xu, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121264 · Cited by 85
Fighting in a wasteland: deleterious metabolites and antitumor immunity
Watson, M. J., & Delgoffe, G. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148549 · Cited by 86
“Lactic acid was found to polarize macrophages toward an M2-like/TAM-like state, including increased arginase 1 (Arg1) expression (42).”
BackgroundJin, M., Cao, W., Chen, B., Xiong, M., & Cao, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.808859 · Cited by 99
“The prominent heterogeneous immune cells in TME are macrophages, whose phenotypes are modulated by distinct signals in TME to exert significant effects on tumor dissemination (Colegio et al., 2014).”
BackgroundLactate Wreaks Havoc on Tumor-Infiltrating T and NK Cells
Scott, K. E. N., & Cleveland, J. L. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.015 · Cited by 90
“Specifically, cancer cells and MDSCs effectively compete with intratumoral CD8+ T and NK cells for essential fuels such as glucose, and their overexpression of arginase suppresses CD8+ T cell activation via deprivation of L-arginine (Arg) (Bronte and Zanovello, 2005), which is rapidly metabolized following CD8+ T cell…”
BackgroundInfluentialWu, Q., Allouch, A., Paoletti, A., Leteur, C., Mirjolet, C., Martins, I., Voisin, L., Law, F., Dakhli, H., Mintet, E., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.91 · Cited by 88
FOXOs in cancer immunity: Knowns and unknowns
Deng, Y., Wang, F., Hughes, T. L., & Yu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.005 · Cited by 90
Keserű, J. S., Soltész, B., Lukács, J., Márton, É., Szilágyi, M., Penyige, A., Póka, R., & Nagy, B. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.04.015 · Cited by 84
Qiu, S., Deng, L., Liao, X., Nie, L., Qi, F., Jin, K., Tu, X., Zheng, X. S., Li, J., Liu, L., et al. (2019) · Cancer Science · doi:10.1111/cas.14078 · Cited by 89
Sun, X., Wang, M., Wang, M., Yao, L., Li, X., Dong, H., Li, M., Sun, T. C., Liu, X., Liu, Y., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00651 · Cited by 86
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Foglia, B., Beltrà, M., Sutti, S., & Cannito, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087463 · Cited by 90
Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis
Yuan, R., Li, S., Geng, H., Wang, X., Guan, Q., Li, X., Ren, C., & Yuan, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.014 · Cited by 85
Cellular metabolism of tumor‐associated macrophages – functional impact and consequences
Rabold, K., Netea, M. G., Adema, G. J., & Netea-Maier, R. T. (2017) · FEBS Letters · doi:10.1002/1873-3468.12771 · Cited by 90
“Previously, it has been shown that increased levels of lactic acid in the tumor microenvironment [77, 78] can reprogram TAMs to a tumor-promoting phenotype by induction of the transcription factor HIF1α [79].”
InfluentialLocatelli, S. L., Careddu, G., Serio, S., Consonni, F. M., Maeda, A., Viswanadha, S., Vakkalanka, S. V. S., Castagna, L., Santoro, A., Allavena, P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1133 · Cited by 82
Song, M., & Cubillos‐Ruiz, J. R. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.001 · Cited by 87
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Le Naour, A., Quemerais, C., Hamel, D., Fournié, J.-J., Couderc, B., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 72
“PPARγ agonists, which are suppressive for the Gpr132 axis, or siRNA silencing of Gpr132, was successfully used to desensitize TAMs to lactate stimulation in a breast tumor model [80,81].”
MethodMetabolic reprogramming supports the invasive phenotype in malignant melanoma
Bettum, I. J., Gorad, S. S., Barkovskaya, A., Pettersen, S., Moestue, S. A., Vasiliauskaite, K., Tenstad, E. M., Øyjord, T., Risa, Ø., Nygaard, V., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.006 · Cited by 85
“[38], or “educate” pro-tumorigenic stromal cells [39].”
Qian, X., Aboushousha, R., van de Wetering, C., Chia, S. B., Amiel, E., Schneider, R. W., van der Velden, J. L. J., Lahue, K. G., Hoagland, D. A., Casey, D. T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.043 · Cited by 88
Zhang, Q., Lou, Y., Bai, X., & Liang, T. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i31.3500 · Cited by 87
Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension
Hudalla, H., Michael, Z., Christodoulou, N., Willis, G. R., Fernandez‐Gonzalez, A., Filatava, E. J., Dieffenbach, P. B., Fredenburgh, L. E., Stearman, R. S., Geraci, M. W., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0232oc · Cited by 82
“Furthermore, proinflammatory activation of tumor-associated macrophages is suppressed by lactic acidosis, whereas alternative activation is enhanced (23).”
BackgroundEffects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds
Sun, J., Xu, X., & Jin, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880286 · Cited by 94
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Wang, J., Qiao, L., Chen, X., & Aifantis, I. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.01.009 · Cited by 85
A Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. N. R., Sherman, J., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 83
Fu, H., Gao, H., Qi, X., Zhao, L., Wu, D., Bai, Y., Li, H., Liu, X., Hu, J. X., & Shao, S. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0290-3 · Cited by 94
“Cancer cells favor aerobic glycolysis to benefit malignancy by decreasing the microenvironmental pH [63, 64], disturbing reactive oxygen species homeostasis [65, 66], regulating chromatin remodeling and contributing to biosynthesis [39–41, 67, 68].”
BackgroundMacrophage Responses to Environmental Stimuli During Homeostasis and Disease
Rasheed, A., & Rayner, K. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab004 · Cited by 91
Khouzam, R. A., Zaarour, R. F., Brodaczewska, K. K., Azakir, B., Venkatesh, G. H., Thiery, J., Terry, S., & Chouaïb, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828875 · Cited by 85
Longhitano, L., Vicario, N., Forte, S., Giallongo, C., Broggi, G., Caltabiano, R., Barbagallo, G. M. V., Altieri, R., Raciti, G., Rosa, M. D., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03215-3 · Cited by 85
Lactate secreted by cervical cancer cells modulates macrophage phenotype
Stone, S. C., Rossetti, R. A. M., Alvarez, K. L. F., Carvalho, J. P., Margarido, P. F. R., Baracat, E. C., Tacla, M., Boccardo, E., Yokochi, K., Lorenzi, N. P. C., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0718-274rr · Cited by 88
Exploitation of Apoptotic Regulation in Cancer
Ucker, D. S., & Levine, J. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00241 · Cited by 85
“In addition, exposure to apoptotic cells upregulates the expression by macrophages and endothelial cells of vascular endothelial growth factor (VEGF)-A, a factor that potently augments vascular permeability (73, 86, 87).”
BackgroundLin, Y., Tan, C., Chen, C.-W., Ou, D., Cheng, A., & Hsu, C. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1673621 · Cited by 84
Ceci, C., Atzori, M. G., Lacal, P. M., & Graziani, G. (2020) · Cancers · doi:10.3390/cancers12113401 · Cited by 85
“Lactic acid produced by tumor cells, known to exert a critical role in inducing M2-like polarization of TAMs, is a key player in promoting ARG-1 expression by macrophages [46].”
BackgroundNaik, A., & Decock, J. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.598626 · Cited by 87
“Indeed, tumor-derived lactate can induce TAM polarization to the M2 immunosuppressive phenotype by binding to the lactate-sensitive receptor GPR132 (91, 120).”
BackgroundInfluentialThe Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ruiz-Iglesias, A., & Mañes, S. (2021) · Cancers · doi:10.3390/cancers13071488 · Cited by 72
“Indeed, lactic acid signals skew macrophages towards the M2 phenotype by inducing the expression of ARG1 [182], which supports tumor growth and inhibits antitumor T cell responses [183].”
BackgroundTargeting Tumor-Associated Macrophages in Cancer Immunotherapy
Petty, A. J., Owen, D. H., Yang, Y., & Huang, X. (2021) · Cancers · doi:10.3390/cancers13215318 · Cited by 74
“Lactic acid, a tumor cell-derived aerobic glycolysis byproduct induces TAM functional polarization through the action of hypoxia inducible factor 1α (HIF-1α) resulting in subsequent promotion of tumorigenesis [26].”
BackgroundLactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies
Jedlička, M., Feglarová, T., Janstová, L., Kohoutková, M. H., & Frič, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932055 · Cited by 86
“Overall, lactate is an omnipresent substance in the TME, and as such it directly influences the outcome of anti-tumor immunity (37, 64, 65).”
BackgroundChang, C.-Y., You, R., Armstrong, D., Bandi, A., Cheng, Y.-T., Burkhardt, P. M., Becerra-Dominguez, L., Madison, M. C., Tung, H.-Y., Zeng, Z., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0615 · Cited by 87
“Lactate has been shown to polarize immune cells to favor tumor progression ( 24 , 37 ).”
Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer
Tu, V. Y., Ayari, A., & O’Connor, R. S. (2021) · Antibodies · doi:10.3390/antib10030025 · Cited by 86
“, identified a novel signaling role for lactate, independent of acidity, in the tumor environment [23].”
BackgroundCombined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis
Vandewalle, J., Timmermans, S., Paakinaho, V., Vancraeynest, L., Dewyse, L., Vanderhaeghen, T., Wallaeys, C., Wyngene, L. V., Looveren, K. V., Nuyttens, L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.002 · Cited by 84
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Truxová, I., Cibula, D., Špíšek, R., & Fucikova, J. P. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005968 · Cited by 83
Hypoxic Microenvironment and Metastatic Bone Disease
Hiraga, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113523 · Cited by 82
“Furthermore, tumor-derived lactic acid, whose levels are elevated by hypoxic metabolism, promotes M2-like polarization in a HIF-1α-dependent manner [56].”
BackgroundEnergy metabolic pathways control the fate and function of myeloid immune cells
Al-Khami, A. A., Rodríguez, P. C., & Ochoa, A. C. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.1vmr1216-535r · Cited by 80
“Additionally, HIF-1a critically controls the hypoxia-induced expression of PD-L1, not only in MDSCs but also in TAMs and DCs [150].”
BackgroundInfluentialShen, S., Liu, M., Li, T., Lin, S., & Mo, R. (2017) · Biomaterials Science · doi:10.1039/c7bm00297a · Cited by 81
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
Petty, A. J., & Yang, Y. (2019) · Cells · doi:10.3390/cells8121526 · Cited by 77
Metabolic heterogeneity and adaptability in brain tumors
Badr, C. E., Silver, D. J., Siebzehnrübl, F. A., & Deleyrolle, L. P. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03569-w · Cited by 78
Gómez, V., Eykyn, T. R., Mustapha, R., Flores‐Borja, F., Male, V. H., Barber, P. R., Patsialou, A., Green, R. J., Panagaki, F., Li, C. W., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax4585 · Cited by 83
Multiple functions of pyruvate kinase M2 in various cell types
Lee, Y.-B., Min, J. K., Kim, J., Cap, K. C., Islam, R., Hossain, A. J., Dogsom, O., Hamza, A., Mahmud, S., Choi, D. R., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30536 · Cited by 90
“Furthermore, VEGF and Arg1 in macrophages contribute to angiogenesis for neovascular formation around the tumor and are required for proliferation of cancer cells (Colegio et al., 2014).”
BackgroundTumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 88
Luo, F., Li, H., Ma, W., Cao, J., Chen, Q., Lu, F., Qiu, M., Zhou, P., Xia, Z., Zeng, K., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01112-y · Cited by 83
“Previous studies have reported that macrophage migration to the tumor microenvironment is a critical event in tumor development [13, 31].”
BackgroundTargeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 89
“In addition, lactate alone or combined with tumor-derived colony-stimulating factor-2 (CSF2) induces macrophage polarization towards tumor-associated macrophages – M2-like macrophages, which are more supportive of tumor progression compared with immune surveillance polarization (M1) [128,131].”
Hutcheson, J., Balaji, U., Porembka, M. R., Wachsmann, M., McCue, P. A., Knudsen, E. S., & Witkiewicz, A. K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1883 · Cited by 80
“Conversely, tumor-derived lactic acid is capable of skewing macrophages toward the antiinflammatory, tumor-promoting M2 phenotype (48).”
Alemán, J. O., Iyengar, N. M., Walker, J. M., Milne, G. L., Da Rosa, J. C., Liang, Y., Giri, D. D., Zhou, X. K., Pollak, M. N., Hudis, C. A., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00020 · Cited by 78
“Lactate has been observed to stimulate M1 polarization of macrophages [31].”
BackgroundLactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization
Song, J., Lee, K., Park, S. W., Chung, H., Jung, D., Na, Y. R., Quan, H., Cho, C. S., Che, J., Kim, J. H., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-23892 · Cited by 81
Lactate Exposure Promotes Immunosuppressive Phenotypes in Innate Immune Cells
Sangsuwan, R., Thuamsang, B., Pacifici, N. J., Allen, R. P., Han, H., Miakicheva, S., & Lewis, J. S. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00652-x · Cited by 82
The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy
Li, Z., Li, Y., Gao, J., Fu, Y., Hua, P., Jing, Y., Cai, M., Wang, H., & Tong, T. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119150 · Cited by 73
Metabolic reprogramming in cervical cancer and metabolomics perspectives
Li, B., & Sui, L. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00615-7 · Cited by 89
“Secreted lactate contributes to anti-inflammatory M2 tumor-associated macrophage polarization and inhibits tumor surveillance by T cells and natural killer (NK) cells [14, 15].”
BackgroundmiR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression
Ma, C., He, D., Tian, P., Wang, Y., He, Y., Wu, Q., Jia, Z., Zhang, X., Zhang, P., Ying, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114006119 · Cited by 73
“Our previous study reported that miR-182 regulates the accumulation of triglyceride in cancer cells (49), while lipid metabolism has been known to be critical for macrophage polarization (71–73).”
Wang, H., Ge, J.-C., Zhang, F., Zha, X., Liu, J., Li, Q.-M., & Luo, J. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119683 · Cited by 76
Targeting lactate metabolism for cancer immunotherapy - a matter of precision
Heuser-Loy, C., Renner, K., Kreutz, M. P., & Gattinoni, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.001 · Cited by 82
Tao, H., Zhong, X., Zeng, A., & Song, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1208870 · Cited by 85
“By stabilizing HIF-1a, lactate could enhance VEGF and Arg1 expression and induces M2-like polarization of TAMs, and VEGF and Arg1 support tumor growth via inducing neovascularization and providing substrates for cancer cell proliferation, respectively (16).”
BackgroundInfluentialMetabolic reprogramming & inflammation: Fuelling the host response to pathogens
Gleeson, L. E., & Sheedy, F. J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.007 · Cited by 90
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Irving, M. B., de Silly, R. V., Scholten, K. B. J., Dilek, N., & Coukos, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00267 · Cited by 80
“Lactic acid can also promote M2-polarization and expression of arginase-1 by HIF-1α stabilization (235).”
BackgroundPharmacological targets of metabolism in disease: Opportunities from macrophages
Castegna, A., Gissi, R., Menga, A., Montopoli, M., Favia, M., Viola, A., & Canton, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107521 · Cited by 81
Leblond, M. M., Zdimerova, H., Desponds, E., & Verdeil, G. (2021) · Cancers · doi:10.3390/cancers13184712 · Cited by 86
“Moreover, hypoxic areas, where TAMs are particularly concentrated in BCa [54], favor M2-like macrophages [60] through intracellular signaling and tumor-derived metabolites [61,62], which could contribute to the accumulation of pro-tumor macrophages in BCa.”
BackgroundZang, S., Huang, K., Li, J., Ren, K., Li, T., He, X., Yuan, T., He, J., Dong, Z., Li, M., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.05.045 · Cited by 80
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 82
Zhou, H., Yu, W., Yan, X., Liang, X., Xiu-feng, M., Long, J., Du, X., Mao, H.-Y., & Liu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013686 · Cited by 85
“(14) demonstrated that the effect of lactate in promoting M2-like polarization of TAMs was mediated by HIF-1a.”
BackgroundLi, L., & Tian, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114504 · Cited by 79
López, E., Karattil, R., Nannini, F., Cheung, G. W.-K., Denzler, L., Gálvez‐Cancino, F., Quezada, S. A., & Pulè, M. A. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006287 · Cited by 82
Su, J., Mao, X., Wang, L., Chen, Z., Wang, W., Zhao, C., Li, G., Guo, W., & Hu, Y. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2320951 · Cited by 81
Metadata
- Authors
- Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R.
- Affiliations
- Yale Cancer Center (US)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- ORCID
- Venue
- Nature
- Published
- 2014-07-13
- Volume
- 513
- Issue
- 7519
- Pages
- 559-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4301845
- OpenAlex
- W2063632665
- Cited by
- 3,046
- References
- 24
- Citations by year
- 2026: 359 · 2025: 338 · 2024: 311 · 2023: 338 · 2022: 345 · 2021: 314 · 2020: 269 · 2019: 213 · 2018: 159 · 2017: 161 · 2016: 113 · 2015: 87 · 2014: 23
- FWCI
- 58.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000142)
- National Cancer Institute (R01CA157461, K08CA172580, P50CA121974, CA157461)
- National Institute of Allergy and Infectious Diseases (AI089771, R01AI089771, R37AI046688, AI046688, R01AI046688)
- National Center for Research Resources (KL2RR024138)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumour-associated macrophages, lactic acid, M2 macrophage polarization, hypoxia-inducible factor-1α, vascular endothelial growth factor, arginase-1, tumor growth, tumor microenvironment, glycolysis, tissue homeostasis
- MeSH terms
- Animals, Arginase, Cell Communication, Cell Division, Female, Glycolysis, Homeostasis, Macrophages, Male, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, RNA, Messenger, Solubility, Up-Regulation, Culture Media, Conditioned, Carcinoma, Lewis Lung, Lactic Acid, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.